115118-93-9

Basic information

• Product Name: ETHYL-N-(2-METHYL-3-NITROPHENYL)FORMIMIDATE
• Synonyms: ETHYL-N-(2-METHYL-3-NITROPHENYL)FORMIMIDATE;N-(2-Methyl-3-nitrophenyl)MethaniMidic Acid Ethyl Ester;ethyl N-(2-methyl-3-nitrophenyl)methanimidate;(E)-ETHYL N-2-METHYL-3-NITROPHENYLFORMIMIDATE
• CAS NO: 115118-93-9
• Molecular Formula: C₁₀H₁₂N₂O₃
• Molecular Weight: 208.21
• Product Categories: Aromatics Compounds;Aromatics
• Mol File: 115118-93-9.mol
• Article Data: 9

Chemical Properties

• Melting Point: 58-59 °C(Solv: hexane (110-54-3); ethyl ether (60-29-7))
• Boiling Point: 323.5±35.0 °C(Predicted)
• Appearance: /
• Density: 1.15±0.1 g/cm3(Predicted)
• Solubility: DMSO, Ethanol
• PKA: 1.93±0.50(Predicted)
• CAS DataBase Reference: ETHYL-N-(2-METHYL-3-NITROPHENYL)FORMIMIDATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL-N-(2-METHYL-3-NITROPHENYL)FORMIMIDATE(115118-93-9)
• EPA Substance Registry System: ETHYL-N-(2-METHYL-3-NITROPHENYL)FORMIMIDATE(115118-93-9)

Safety Data

• Hazardous Substances Data: 115118-93-9(Hazardous Substances Data)

Usage

Description

ETHYL-N-(2-METHYL-3-NITROPHENYL)FORMIMIDATE, with the CAS number 115118-93-9, is a light green crystalline solid that serves as a valuable compound in the realm of organic synthesis. Its unique chemical structure contributes to its potential applications in various industries.

Uses

Used in Organic Synthesis:
ETHYL-N-(2-METHYL-3-NITROPHENYL)FORMIMIDATE is used as a synthetic intermediate for the creation of various organic compounds. Its chemical properties allow it to be a versatile building block in the synthesis of a wide range of molecules, including pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, ETHYL-N-(2-METHYL-3-NITROPHENYL)FORMIMIDATE is used as a key component in the development of new drugs. Its unique structure can be utilized to create novel therapeutic agents that target specific biological pathways, potentially leading to the discovery of innovative treatments for various diseases and conditions.
Used in Agrochemical Industry:
ETHYL-N-(2-METHYL-3-NITROPHENYL)FORMIMIDATE also finds application in the agrochemical industry, where it is used as a starting material for the synthesis of new pesticides and other crop protection agents. Its incorporation into these products can enhance their effectiveness in protecting crops from pests and diseases, ultimately contributing to increased agricultural productivity.
Used in Research and Development:
In the field of research and development, ETHYL-N-(2-METHYL-3-NITROPHENYL)FORMIMIDATE serves as an important compound for exploring new chemical reactions and understanding the underlying mechanisms. Its use in this context can lead to the discovery of new synthetic methods and the development of more efficient and environmentally friendly processes in the chemical industry.

Upstream product

• 603-83-8 3-nitro-o-tolylamine 
• 122-51-0 orthoformic acid triethyl ester 

Downstream Products

• 91482-63-2 1-methyl-4-nitro-1H-indole 
• 4769-97-5 4-nitro-1H-indoIe 
• 115118-94-0 N¹,N²-bis(2-methyl-3-nitrophenyl)amidine 
• 133053-95-9 1,3-bis(trifluoroacetyl)-2-(4-nitro-3-indolyl)-4-imidazoline 
• 79473-09-9 4-azidoindole-3-acetic acid 
• 7150-46-1 4-nitrogramine 
• 90947-20-9 (4-nitroindol-3-yl)-2-oxoacetic acid 
• 81038-41-7 1-methoxycarbonyl-4-nitroindole 
• 81038-30-4 4-amino-1-methoxycarbonylindole 
• 478916-44-8 2-carboxyl-3-methyl-3,5-dihydro-2H-thiopyrano[4,3,2-cd]indole 
• 81038-38-2 4-iodo-1H-indole 
• 85696-95-3 1-methyl-1H-indol-4-amine 
• 852715-69-6 3-phenyl-3-(1-methylindol-4-ylamino)acrylic acid ethyl ester 
• 91974-30-0 ethyl (4-nitroindol-3-yl)-2-oxoacetate 

Relevant articles and documents

A medicine intermediate 4 - nitro indole preparation process (by machine translation)

The present invention discloses a pharmaceutical intermediate 4 - nitro indole preparation process, which belongs to the field of pharmaceutical intermediates. The invention relates to 2 - methyl - 3 - nitroaniline with the original carboxylic acid triethyl ester as raw material, in the sulfonic acid type cation exchange resin and common under the catalysis of the sodium tartrate, for 95 - 105 °C lower, reaction generating N - (2 - methyl - 3 - nitrophenyl) b [...] imine, N - (2 - methyl - 3 - nitrophenyl) b oxygen radical armor imine with strong alkali and diethyl oxalate phosphite to produce 4 - nitro indole. The invention two-step process of 4 - nitro indole, intermediate does not need purification, simplifies the process, and avoiding the loss of the product; at the same time the process of the invention, simple post-treatment, the product has high purity, the purification process of product loss, high yield. (by machine translation)

A 4-nitro-indole synthesis method (by machine translation)

The invention discloses a 4-nitro-indole synthesis method, which belongs to the field of chemical synthesis, in order to 2-methyl-3-nitroaniline with the original a acid tri-ethyl ester in 100 °C under catalysis and benzoic acid, the reaction 1.5-2h generating N-(2-methyl-3-nitrophenyl) b oxygen radical armor imine, N-(2-methyl-3-nitrophenyl) b oxygen radical armor imine with sodium ethoxide and oxalic acid bis ethyl ester in 40 °C reaction 1.5h, to produce 4-nitro indole crude product, 4-nitro indole crude product after recrystallizing and sublimation reaction to obtain the 4-nitro-indole. The method of the invention in the prior art to the process parameters on the basis of optimizing one by one, the overall yield of the reaction, reduce the reaction time, improve the synthesis economic benefits. (by machine translation)

Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones

In our search for potential new anticancer drugs, we designed and synthesized a series of tricyclic compounds containing the antimitotic 2-phenylazaflavone chromophore fused to a pyrrole ring in a pyrroloquinoline structure. Compounds 8, 18, 19, 22, 23, 25 and 26, when tested against a panel of fourteen human tumor cell lines, showed poor in vitro cytotoxic activity, whereas 20, 21 and 24 showed significant activity (IC50 0.7 to 50 μM). Steroid hormone-sensitive ovary, liver, breast and adrenal gland adenocarcinoma cell lines displayed the highest sensitivity (IC50 0.7 to 8 μM). Compound 24 blocked cells in the G2/M phase of the cell cycle and induced a significant increase in apoptotis. Compounds 20, 21 and 24 proved to alter microtubule assembly and stability, displaying a cytoplasmic microtubule network similar to that caused by Vincristine. In vivo, administration of compound 24 to Balb/c mice inhibited the growth of a syngenic hepatocellular carcinoma.